Readership
Biologists, Infectious Disease Specialists, Microbiologists, Oncologists, Pharmacologists
Scope
The Journal of Antimicrobial Chemotherapy is a journal of the British Society for Antimicrobial Chemotherapy (BSAC) and is among the foremost international journals in antimicrobial research. Our readership includes representatives of academia, industry and health services, and includes those who are influential in formulary decisions.
Published monthly, the Journal features original articles on the laboratory aspects and clinical use of antimicrobials including antibacterial, antiviral, antifungal, and antiprotozoal agents.
In addition to the wealth of primary papers, the journal carries review articles offering in-depth discussion on matters of topical concern. Lively leading articles offer incisive coverage of recent advances and controversies.
Other sections include: For debate : International comment on contentious issues and ideas; Antimicrobial practice: Articles on practical prescribing and formulary issues; Correspondence : A section for scientists to present early observations of their work and to comment on published articles; Book reviews : Helpful reviews of relevant, newly published titles.